Company Filing History:
1 out of 2,405 
1 out of 559 
1 out of 512 
Years Active: 2013-2025
Title: Innovations and Contributions of Inventor Xingyue He
Introduction
Xingyue He is a prominent inventor based in Cambridge, MA, known for his significant contributions to the field of biomedical research. He holds a total of three patents, showcasing his innovative approach to addressing complex medical challenges.
Latest Patents
One of his latest patents is titled "Chimeric receptors targeting ADGRE2 and/or CLEC12A and uses thereof." This patent provides for chimeric receptors that specifically target ADGRE2 and CLEC12A. The disclosed subject matter includes cells that comprise these targeted chimeric receptors, which have potential applications in treating tumors, such as acute myeloid leukemia (AML). Another notable patent is "Compositions and methods for generating induced pluripotent stem cells." This patent outlines a method for generating induced pluripotent stem cells (iPSCs), along with nucleic acids and genetically modified host cells that are useful in this process.
Career Highlights
Xingyue He has worked with esteemed organizations, including Merck Sharp & Dohme Corporation and Memorial Sloan Kettering Cancer Center. His experience in these institutions has contributed to his expertise in the development of innovative medical solutions.
Collaborations
Throughout his career, Xingyue He has collaborated with notable colleagues, including Lin He and Gregory J. Hannon. These collaborations have further enhanced his research and development efforts.
Conclusion
Xingyue He is a distinguished inventor whose work in developing chimeric receptors and induced pluripotent stem cells has the potential to revolutionize cancer treatment and regenerative medicine. His contributions continue to impact the scientific community and pave the way for future innovations.